Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takehiko Sakai

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Breast Cancer (Tokyo, Japan)|May 8, 2025
Japanese translation of the Functional Assessment of Cancer Therapy-Breast + 4 (FACT-B + 4) following international guidelines: a verification of linguistic validityTakahiro Tsukioki, Nozomu Takata, Saya R Dennis, et al.
Breast Cancer Research and Treatment|March 22, 2023
Phase III study of long-term prognosis of estrogen receptor-positive early breast cancer treated with neoadjuvant endocrine therapy with/without adjuvant chemotherapyHiroji Iwata, Yutaka Yamamoto, Takehiko Sakai, et al.
Breast Cancer (Tokyo, Japan)|June 17, 2026
Prognosis of ER-positive, HER2-negative postmenopausal early breast cancer patients based on response to neoadjuvant endocrine therapy and multigene assay results: findings from the NEOS trialHiroji Iwata, Norikazu Masuda, Yutaka Yamamoto, et al.
International Journal of Radiation Oncology, Biology, Physics|December 6, 2011
Influence of lymphatic invasion on locoregional recurrence following mastectomy: indication for postmastectomy radiotherapy for breast cancer patients with one to three positive nodesRyoichi Matsunuma, Masahiko Oguchi, Tomoko Fujikane, et al.
Breast Cancer (Tokyo, Japan)|April 3, 2024
The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatmentYutaka Yamamoto, Chikako Yamauchi, Tatsuya Toyama, et al.
American Journal of Surgery|December 15, 2016
Surgical excision without whole breast irradiation for complete resection of ductal carcinoma in situ identified using strict, unified criteriaTakehiko Sakai, Takuji Iwase, Natsuki Teruya, et al.
International Journal of Clinical Oncology|January 22, 2026
Clinical complete response and predictive factors in HER2-positive early breast cancer treated with neoadjuvant chemotherapy aimed at omission of surgery: an exploratory analysis of the JCOG1806 trialHideo Shigematsu, Tomomi Fujisawa, Fumikata Hara, et al.
Springerplus|July 25, 2015
Decreased hormonal sensitivity after childbirth rather than the tumor size influences the prognosis of very young breast cancer patientsMasujiro Makita, Takehiko Sakai, Akemi Kataoka, et al.
Japanese Journal of Clinical Oncology|January 30, 2026
A randomized controlled trial of metastasis-directed therapy for oligometastases in breast cancer: OLIGAMI trial (JCOG2110)Keita Sasaki, Toshiyuki Ishiba, Ikuno Nishibuchi, et al.
Breast Cancer Research : BCR|June 16, 2025
Axillary adipose tissue-derived lymphatic endothelial cells exhibit distinct transcriptomic signatures reflecting lymphatic invasion status in breast cancerAsumi Iesato, Jun Suzuka, Kazutaka Otsuji, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Breast Cancer (Tokyo, Japan)|May 8, 2025
Japanese translation of the Functional Assessment of Cancer Therapy-Breast + 4 (FACT-B + 4) following international guidelines: a verification of linguistic validityTakahiro Tsukioki, Nozomu Takata, Saya R Dennis, et al.
Breast Cancer Research and Treatment|March 22, 2023
Phase III study of long-term prognosis of estrogen receptor-positive early breast cancer treated with neoadjuvant endocrine therapy with/without adjuvant chemotherapyHiroji Iwata, Yutaka Yamamoto, Takehiko Sakai, et al.
Breast Cancer (Tokyo, Japan)|June 17, 2026
Prognosis of ER-positive, HER2-negative postmenopausal early breast cancer patients based on response to neoadjuvant endocrine therapy and multigene assay results: findings from the NEOS trialHiroji Iwata, Norikazu Masuda, Yutaka Yamamoto, et al.
International Journal of Radiation Oncology, Biology, Physics|December 6, 2011
Influence of lymphatic invasion on locoregional recurrence following mastectomy: indication for postmastectomy radiotherapy for breast cancer patients with one to three positive nodesRyoichi Matsunuma, Masahiko Oguchi, Tomoko Fujikane, et al.
Breast Cancer (Tokyo, Japan)|April 3, 2024
The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatmentYutaka Yamamoto, Chikako Yamauchi, Tatsuya Toyama, et al.
American Journal of Surgery|December 15, 2016
Surgical excision without whole breast irradiation for complete resection of ductal carcinoma in situ identified using strict, unified criteriaTakehiko Sakai, Takuji Iwase, Natsuki Teruya, et al.
International Journal of Clinical Oncology|January 22, 2026
Clinical complete response and predictive factors in HER2-positive early breast cancer treated with neoadjuvant chemotherapy aimed at omission of surgery: an exploratory analysis of the JCOG1806 trialHideo Shigematsu, Tomomi Fujisawa, Fumikata Hara, et al.
Springerplus|July 25, 2015
Decreased hormonal sensitivity after childbirth rather than the tumor size influences the prognosis of very young breast cancer patientsMasujiro Makita, Takehiko Sakai, Akemi Kataoka, et al.
Japanese Journal of Clinical Oncology|January 30, 2026
A randomized controlled trial of metastasis-directed therapy for oligometastases in breast cancer: OLIGAMI trial (JCOG2110)Keita Sasaki, Toshiyuki Ishiba, Ikuno Nishibuchi, et al.
Breast Cancer Research : BCR|June 16, 2025
Axillary adipose tissue-derived lymphatic endothelial cells exhibit distinct transcriptomic signatures reflecting lymphatic invasion status in breast cancerAsumi Iesato, Jun Suzuka, Kazutaka Otsuji, et al.
Pageof 6